Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inga Kadish

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
Chemical Communications (Cambridge, England)|March 15, 2018
Inhibition of amyloid Aβ aggregation by high pressures or specific d-enantiomeric peptidesItalo A Cavini, Claudia E Munte, Markus Beck Erlach, et al.
Scientific Reports|November 28, 2017
The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathologyThomas van Groen, Sarah Schemmert, Oleksandr Brener, et al.
Journal of Alzheimer'S Disease : JAD|April 13, 2012
Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's diseaseJames L Searcy, Jeremiah T Phelps, Tristano Pancani, et al.
ACS Chemical Neuroscience|July 11, 2012
Oral treatment with the d-enantiomeric peptide D3 improves the pathology and behavior of Alzheimer's Disease transgenic miceSusanne Aileen Funke, Thomas van Groen, Inga Kadish, et al.
Scientific Reports|September 24, 2015
QIAD assay for quantitating a compound's efficacy in elimination of toxic Aβ oligomersOleksandr Brener, Tina Dunkelmann, Lothar Gremer, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Chemical Communications (Cambridge, England)|March 15, 2018
Inhibition of amyloid Aβ aggregation by high pressures or specific d-enantiomeric peptidesItalo A Cavini, Claudia E Munte, Markus Beck Erlach, et al.
Scientific Reports|November 28, 2017
The Aβ oligomer eliminating D-enantiomeric peptide RD2 improves cognition without changing plaque pathologyThomas van Groen, Sarah Schemmert, Oleksandr Brener, et al.
Journal of Alzheimer'S Disease : JAD|April 13, 2012
Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer's diseaseJames L Searcy, Jeremiah T Phelps, Tristano Pancani, et al.
ACS Chemical Neuroscience|July 11, 2012
Oral treatment with the d-enantiomeric peptide D3 improves the pathology and behavior of Alzheimer's Disease transgenic miceSusanne Aileen Funke, Thomas van Groen, Inga Kadish, et al.
Scientific Reports|September 24, 2015
QIAD assay for quantitating a compound's efficacy in elimination of toxic Aβ oligomersOleksandr Brener, Tina Dunkelmann, Lothar Gremer, et al.
Pageof 6